Skip to main content
Clinical Trials/NCT03752450
NCT03752450
Completed
Not Applicable

Insight in the Development and Recovery of Hypernatremia in Critically Ill Patients.

Catharina Ziekenhuis Eindhoven1 site in 1 country200 target enrollmentMay 25, 2018
ConditionsHypernatremia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypernatremia
Sponsor
Catharina Ziekenhuis Eindhoven
Enrollment
200
Locations
1
Primary Endpoint
Development of hypernatremia
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Hypernatremia is frequently encountered in patients admitted to the Intensive Care Unit (ICU) and associated with increased mortality and length of stay. Previous studies focused on predictors in the development and recovery of hypernatremia by including amount and types of administered medication, fluid balance, laboratory results and changes in vital signs. However, data of larger populations or data on infusion rates, fluid and salt balance or renal replacement therapy is lacking. This study aims to provide better insight in the development and recovery of hypernatremia through the collection of detailed information on the input and output of fluids and salts in a larger group of patients than studied before.

Detailed Description

Hypernatremia is frequently encountered in patients admitted to the Intensive Care Unit (ICU) and associated with increased mortality and length of stay. The main mechanism is an imbalance between sodium and total body water. Consequently, this poses multiple factors to play a role in the development of hypernatremia. multifactorial. Previous studies focused on predictors in the development of hypernatremia by including amount and types of administered medication, fluid balance, laboratory results and changes in vital signs. However, data of larger populations or data on infusion rates, fluid and salt balance or renal replacement therapy is lacking. Few studies investigated the recovery of hypernatremia, which showed that correction of hypernatremia can reduce the associated mortality risk. This study aims to provide better insight in the development and recovery of hypernatremia through the collection of detailed information on the input and output of fluids and salts in a larger group of patients than studied before.

Registry
clinicaltrials.gov
Start Date
May 25, 2018
End Date
April 10, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Catharina Ziekenhuis Eindhoven
Responsible Party
Principal Investigator
Principal Investigator

Eveline Mestrom

Doctor of Medicine, Principal Investigator

Catharina Ziekenhuis Eindhoven

Eligibility Criteria

Inclusion Criteria

  • Adults \>17 years old
  • Admitted \>48 hours in ICU

Exclusion Criteria

  • Expected discharge same day as day of inclusion

Outcomes

Primary Outcomes

Development of hypernatremia

Time Frame: During ICU admission

Serum sodium levels \>145mmol/L

Recovery of hypernatremia

Time Frame: During ICU admission

Serum sodium levels returning back to levels below 146mmol/L

Secondary Outcomes

  • Mortality(During ICU admission as well as during hospital admission)
  • Length of stay(Admission in ICU as well as in hospital)

Study Sites (1)

Loading locations...

Similar Trials